variables, subsets of patients \\ith markedly different prognoses could be generated. It is possible to predict a favorable outcome for patients with less than 10% positÍ\'e nades, no extranodal disease, and a primary lesion at a site other than the trunk. It is also possible to recognize that the prognosis is very poor for patients \\ith extranodal disease and truncal primary lesions, regardless of the percentage of positive lymph nades. Finally it \\'as verified that the prognosis is al\\'ays unfavorable \\'hen the percentage of positÍ\'e lymph nades is very high. pc (superficial) and proximal (deep) positive nades also was assessed. [10] [11] [12] [13] The prognostic influence of lymph node-related variables previously has not been examined exclusively for patients undergoing axillary lymph nade dissection (ALND). In ibis study a group of patients with proved melanoma metastatic to axillary n.°des following ALND was analyzed.
The main objective was to determine whether further prognostic information can be obtained in the patient with malignant melanoma undergoing ALND ifwe append to the clinical preoperative data the pathologist's evaluation of the surgical specimen.
A PRIMARY DETERMINANT of prognosis in malignant melanorila is the presence or absence of pathologically involved lymph nodes. Oetailed analyses of lymph node status has demonstrated the significance of absolute number-s and percentage2,3 of positive nodes, macroscopic versus microscopic nodal involvement,2.9 and extranodal melanoma at node dissection. 7 In ilioinguinal dissection the significance of distal
Patients and Methods
The medical records of 197 patients with melanoma metastatic to axillary nades undergoing ALND at Memorial Sk>an-Kettering Cancer Center between 1974 and 1984 were reviewed.
Stage was defined according to the American Joint Committee on Cancer (AJCC) system proposed in 1983 (Table 1 ).14 AII patients classified as pathologic stage 111 were included. Ten cases in which the largest lymph nade ranged from 6 to 9 cm were included in the study group. This allowed a full evaluation ofthe importance oflymph nade size. Excluded from the analysis were patients with metastases to two nodal groups, and patients with intransit or distant metastases.
The prognostic importance ofthe following non-lymph node-related variables was evaluated: patient sex, age, primary site, level, thickness, ulceration, and clinical stage. The primary site was designated as upper extremity, trunk, !?6 BEVILACQUA AND OTHERS Ann. Sur¡.. August 1990 thologist described the presence of visible or palpable disease in the surgical specimen that was subsequently confirmed histologically. If neither the surgeon nor the pathologist described visible or palpable disease in the surgical specimen and histologic review subsequently revealed metastatic melanoma, the nodal involvement was classified as microscopic.
The surgical technique followed well-established routines for ALND and included removal ofthe entire axillary contents, with the pectoralis minor muscle, up to and including the levelllllymph nodes medial to it, exposing the costoclavicular ligamento
The purpose of the operation was therapeutic in ISO patients classified as clinical stage 111, while the intent was prophylactic in 47 patients who were clinically understaged as lB, IIA, or IIB ( Table 2) .
The main objective of the statistical analysis was to assess the dependence of fue rate of death from melanoma on the explanatory variables. Time was measured from the date of ALND to the date of death or last follow-up. Survival was estimated for each variable by ti}e productlimit method ofKaplan and Meier.~s Log rank testl6 was used to check for dependence of survival on each variable taken one at a time.
Proportional hazards regressionl7 was used to incorporate all the explanatory variables in the same modelo Forward stepwise procedure and likelihood ratio tests were used to select the variables with the greatest prognostic value. Interaction effects among the variables were also considered. The adequacy of the proportional hazard model to the data was checked by fitting separate proportional hazard madels to partitions of the data determined by a given categorical variable. The coefficients estimated for each partition should not differ substantially unless there was an interaction effect. Cumulative hazard plots were also generated to visually check the assumption of the proportionality of the hazard rates.
Whereas in the univariate analysis age, primary lesion thickness, number of positive nades, percentage of positive nodes, and size of the largest nade were used to generate subsets of categorical variables, in the proportional hazards regression they were treated as continuous variables.
Pairwise associations between variables were evaluated by a t test for linear correlation (two continuous variables), one-way analysis of variante (categorical versus continuous variables), or a contingency table analysis using a chi square or an exact test (two categorical variables). 18 To display the relationship of a continuous variable and survival time, a predictive plot was generated. The predicted median survival for a given set of covariates x is the time t such that
where ,fj is the proportional hazards regression coefficient, or unknown (when patient and physician were unable to determine its site). Extremity lesions were further divided into proximal and distal to the elbow. Trunk lesions were classified as midline when they were located within 3 cm oribe midline and were otherwise considered lateral. Clark level and Breslow thickness of alllesions not removed at Memorial Sloan-Kettering Cancer Center were reviewed by a pathologist ofthis hospital before ALND. We used a broad definition of ulceration that included all patients describing bleeding of the lesion with minor trauma as well as those with ulceration reported on histologic review. The Iymph node-related variables analyzed included the number of positive lymph nodes, the percentage of positive nodes (number ofpositive/total number removed X 100), the size of the largest positive lymph node (in millimeters), the highest nodal status, the level of the highest positive node, the invasion ofsoft tissue from diseased nodes (extranodal disease), and the gross nodal appearance (macroscopic versus microscopic metastases).
The highest nodal status was described as positive when the highest dissected lymph node was affected by metastatic melanoma.
The level of the highest positive node was referred to as 1 when lateral, 11 when behind, and III when medial to the pectoralis minor muscle.
The gross nodal appearance was defined as macroscopic when either the operating surgeon or the prospecting pa-
The following lymph node-related variables were"prognostically important by uriivariate analysis: number and percentage of positive lymph nodes, highest nodal status, presence or absence of extranodal disease, and microscopic or macroscopic nodal appearance (Table 3) . Conversely the size ofthe largest positive node (p = 0.87) and the level of the highest positive node (p = 0.78) were of no prognostic value.
In the multivariate analysis, only variables that were significant in the univariate approach were considered. From the 197 patients, only 147 had complete information on all these variables and these made up the the multivariate sample. Three variables were selected into the final proportional hazards regression: percentage of positive lymph nodes, extranodal disease, and site ofthe primary lesiono No other lymph node-related variable showed independent prognostic importance in the proportional hazard regression. The hypothesis that all the regression coefficients were zero was rejected (p < 0.001). Table 4 Ann. Sur¡. ' August 1990 shows the summary ofthe multivariate analysis in terms of likelihoad ratio tests, coefficients, and standard errors of the selected variables. Table 5 shows the associations between lymph noderelated variables. Percentage of positive nades and extranadal disease, variables that were selected in the multivariate model, are uncorrelated. The other variables, which were not selected in, are highly correlated, mainly with percentage.
As most previous investigators have considered the absolute number rather iban percentage of positive nades, the association ofabsolute number, percentage, and total number of recovered nades \\'as further analyzed. The correlation between percentage and number of positive nades was high (r = 0.85, p < 0.001). Percentage of positive nades did not correlate with the total number of recovered nades (r = 0.05, p = 0.13). Using the same cutoff points defined in the univariate analysis, Table 6 shows that a low positive lymph nade percentage (10% The number ofrecovered nades varied from la to 59 for the patients with a positive nade percentage of 10% or less, which is similar to the range of 4 to 67 for patients with a positive nade percentage greater iban 10%. Therefore, in the absence of a correlation between the number ofpositive nades and the total number ofrecovered nades, the possibility of a pathology bias (9fthe type 'the more you search the more you find') can be discarded.
In ibis groupoflymph node-positive patients, the survival of clinical stage less iban 111 versus clinical stage 111 patients was significantly different in the univariate analysis (Table 2 ). However ibis variable was notincluded in the multivariate modelo This can be explained by the association of clinical stage and percentage of positive nades. The percentage of positive nades in the subset of clinical stage less iban 1lI was 9.5% (:t6.3%) and in clinical stage 111 it was 16.5% (:t20%), a significant difference by t test (p = 0.03).
The prognosis in node-positive patients is expressed as the estimated median survival rate in months in Figure   100 PDSITIVE NDDES . with positive nodes will die, even ifthe Iymphadenéctomy -is performed when the nades are clinically negative. Conversely some patients with clinically and pathologically positive nades removed will survive. This demonstrates the importance of defining variables that could help in the definition of true locoregional disease. Although OUT primary interest was to evaluate lymph node-related variables, truncal versus nontruncal site was ultimately included in OUT considerations because it was the only non-lymph node-related variable maintaining significance both in the univariate and multivariate analyses. This finding contrasts with the results of other studies in stage 111 malignant melanomaS.22 in which site was not an independent predictor of outcome. As shown in Table  2 , site was significant only when subdivided into two groups, trunk and nontrunk. Further subdivision of site into proximal \'ersus distal extremity or midline versus lateral trunk obscured its significance as an independant predictor of outcome.
Five lymph node-related variables, number and percentage ofpositive nades, status ofthe highest nade, macroscopic nodal appearance, and presence of extranodal disease, were statistically significant by the univariate analysis. Only two of these, percentage of positive nades and presence of extranodal disease, were independent predictors of survival in the multivariate analysis. This disagreement is only apparent because most bf the significant univariate variables are associated with percentage of positive nades (Table 5) .
Two lymph node-related variables, level of the highest positive nade and size of the largest lymph nade, were not significant in predicting survival, even in the univariate analysis.
The level ofthe highest positive lymph nade is ~ concept borrowed from breast cancer surgery were it was introduced by Berg23 in 1955 at Memorial Sloan-Kettering Cancer Center. However it is important to note that, even for these tumors, this variable was not universally accepted as an independant predictor of survival. Smith et al?4 have shown that when breast cancer patients with equal numbers of positive nades are considered there is no statistically significant difference in survival when stratified by the level of positive nades.
The outcome related to this variable in the present study may have been obscured by another factor. The information concerning the level ofthe highest positive Iymph nade was missing in 68% ofthe studied patients. This fact limits its power in estimating prognosis. On the other hand, we observed a statistically significant association betwe~n this variable and percentage of positive lymph nodes: This raises the possibility thatany information that could possibly be derived from the level ofhighest positive Iymph node is already represented in the final model by the percentage of positive nades. Ann Sur¡.. AuBUSl 1990 Size of the largest positive lymph node is included in the AJCC staging system as a significant prognostic factor in patients with melanoma metastatic to regional nodes (Table 1) . In this review, however, this variable was not significant, even in the univariate analysis. This negative result is strengthened by the fact that this observation was available for 138 (70%) of the patients. Furthermore it must be stressed that patients with very large nodes (in 10 cases measuring more than 5 cm) were included in the study group. Another important finding was that size of the largest node and percentage of positive lymph nodes bear a statisticalIy significant correlation (r = 0.35, p < 0.001) and we could repeat here the comments already made for the level of highest positive node.
The majority of studies analyzing lymph node-related variables in stage 111 melanoma have concluded that the number of positive lymph nodes is the most significant prognostic factor.I-8 In this study both percentage and absolute number ofpositive nodes were significant in the univariate analysis. Of these two highly correlated variables (r = 0.85), percentage was the more predictive of survival and hence was selected intothe final mulitvariate modelo
The analysis ofFigure 1, in which the predicted median survival time of four groups of patients is represented, led us to some important conclusions. It clearly indicates that it is possible to prediet a very favorable outcome for patients with less than 10% positive nodes, no extranodal disease, and primary lesion at a site other than trunk, independent of primary lesion thickness. It also shows that the prognosis is very poor in patients with extranodal disease and truncal primary lesions, regardless the percentage ofpositive lymph nodes. FinalIy it confirms that when the percentage ofpositive lymph nodes is very high, the prognosis is unfavorable for any combination ofthose two other significant variables.
The favorable prognosis of patients with clinicalIy negative but histologically positive regional nodes (pathologic stage 111 and clinical stage less than 111) relative to that of patients with clinically and histologically positive regional nodes, has been reported by several authors.2,4 In this review we found this to be true only in the univariate analysis. Patients who were clinicalIy staged less than 111 had a significantly lower percentage of positive nodes. Therefore we must conclude that any possible prognostic advantage in this subset ofpatients must be associated with a lower tumor burden. Both univariate and multivariate analysis demonstrated the prognosticimportance of a low percentage of positive lymph nodes and absence of extranodal disease. In addition to that smalI number of positive lymph nodes, microscopic disease and negative highest dissected lymph node were also univariately significant. AII these elements are indicators of limited regional involvement.
Although this paper was not designed to anaIyze the timing of ALND, it re-emphasizes the importance of early regional control of the disease, which should be achieved by an elective operation or by short follow-up intervals:25
